A Danish registry study involving 756,636 pregnancies found that the association between GLP-1 receptor agonists and increased risk of preterm birth was seen only among those who used the medications for diabetes, with no significant association among those using them for weight management. The study evaluated semaglutide and liraglutide, with 529 pregnancies having records indicating possible use during early pregnancy; after adjusting for factors such as the pregnant person’s age, BMI, and smoking, the adjusted odds of preterm birth among those taking the medications for diabetes increased by 70% and 84%, respectively.
Source:ScienceDaily · Read Original
Leave a Reply